C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/48 (2006.01) A61K 31/506 (2006.01) A61P 11/00 (2006.01) A61P 13/00 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2620129
Compounds and methods for treating diseases mediated by a P2X3 and/or a P2X2/3 receptor antagonist, the compounds being of formula (I) wherein D, X, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein.
La présente invention concerne des composés et des procédés de traitement de maladies facilitées par un P2X3 et/ou un antagoniste du récepteur P2X2/3, les composés étant de formule (I) où D, X, R1, R2, R3, R4, R5, R6, R7 et R8 sont définis ici.
Dillon Michael Patrick
Jahangir Alam
Lin Clara Jeou Jen
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Diaminopyrimidines as p2x3 and p2x2/3 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diaminopyrimidines as p2x3 and p2x2/3 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaminopyrimidines as p2x3 and p2x2/3 modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1637260